Bonini, C
Peccatori, J
Stanghellini, M T L
Vago, L
Bondanza, A
Cieri, N
Greco, R
Bernardi, M
Corti, C
Oliveira, G
Zappone, E
Traversari, C
Bordignon, C
Ciceri, F
Article History
First Online: 3 June 2015
Competing interests
: Prof. Claudio Bordignon and Dr Catia Traversari are employees of MolMed S.p.A., Milano, Italy. Prof. Bordignon also owns stock/equity in MolMed S.p.A. Chiara Bonini receives a research grant from MolMed s.p.a and has been a consultant of MolMed s.p.a. Attilio Bondanza has received grant support from Italian Association for Cancer Research and holds a patent ‘Use of common y-chain cytokines for the genetic modification of memory T lymphocytes’ EP1946080, US13240,009.